View Older Stories View More Recent Stories

Apr 22, 2026 09:38AM William Blair on Kyverna Therapeutics Inc (KYTX): AAN updates 'extremely positive,' data supports BLA
Apr 22, 2026 07:03AM Kyverna reports positive trial results for SPS treatment
Mar 26, 2026 04:24PM Kyverna Therapeutics (KYTX) files $300M mixed shelf
Jan 12, 2026 08:09AM Kyverna appoints Christi Shaw as executive chairperson, plans 2026 BLA filing
Dec 15, 2025 02:34PM Kyverna Therapeutics Inc (KYTX) PT Raised to $33 at Morgan Stanley
Dec 15, 2025 06:30AM Kyverna reports positive trial results for autoimmune therapy
Nov 13, 2025 05:05PM Kyverna Therapeutics, Inc. (KYTX) Tops Q3 EPS by 17c
Nov 3, 2025 08:03AM Kyverna Therapeutics secures $150 million loan facility from Oxford Finance
Oct 27, 2025 06:49AM Kyverna Therapeutics Inc (KYTX) PT Raised to $20 at H.C. Wainwright
Oct 8, 2025 06:01AM Kyverna Therapeutics Inc (KYTX) PT Raised to $27 at Wells Fargo
Sep 25, 2025 04:10PM Kyverna board member Liapis to resign Sept. 30
Sep 25, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Kyverna Therapeutics Inc (KYTX)
Aug 29, 2025 06:53AM Kyverna Therapeutics Inc (KYTX) PT Raised to $10 at H.C. Wainwright
Aug 20, 2025 05:06AM William Blair Starts Kyverna Therapeutics Inc (KYTX) at Outperform
Aug 12, 2025 06:06PM Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 5c
Jun 30, 2025 09:03AM Kyverna Therapeutics (KYTX) names Marc Grasso as CFO
May 14, 2025 05:21PM Kyverna Therapeutics, Inc. (KYTX) Reports Q1 Loss of $1.03
Apr 3, 2025 06:46AM Kyverna Therapeutics Inc (KYTX) PT Lowered to $4 at H.C. Wainwright
Mar 27, 2025 04:53PM Kyverna Therapeutics (KYTX) Files $250M Mixed Shelf
Mar 14, 2025 12:52PM GRABAR LAW OFFICE INVESTIGATES CLAIMS ON BEHALF OF SHAREHOLDERS OF KYVERNA THERAPEUTICS, INC. (KYTX)
Feb 6, 2025 07:24PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Feb 4, 2025 10:28AM KYTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - KYTX
Feb 3, 2025 05:44PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Feb 2, 2025 09:00AM KYTX FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - KY
Jan 29, 2025 10:00AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - KYTX
Jan 28, 2025 06:33PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 27, 2025 01:44PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 26, 2025 02:31PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 26, 2025 08:13AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 25, 2025 12:18PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 23, 2025 11:05PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 23, 2025 03:16PM KYTX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. (KYTX)
Jan 22, 2025 08:54PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 21, 2025 04:07PM Kyverna Therapeutics (KYTX) Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
Jan 19, 2025 08:04AM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 18, 2025 04:15PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 16, 2025 07:03PM ROSEN, A LEADING LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 15, 2025 06:58PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 14, 2025 06:58PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 13, 2025 07:05PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 12, 2025 03:23PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 11, 2025 06:49AM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 9, 2025 10:33PM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 9, 2025 01:32PM KYTX Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Kyverna Therapeutics, Inc.
Jan 8, 2025 05:06PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 4, 2025 08:08PM ROSEN, A RANKED AND LEADING FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 4, 2025 09:06AM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 3, 2025 05:28PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 3, 2025 02:01PM KYTX Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Jan 2, 2025 11:31AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
View More Recent Stories View Older Stories